STALICLA signs Cooperative Research and Development Agreement (CRADA) with US National Institute on Drug Abuse (NIDA) to cover Phase 3 development of mavoglurant in cocaine use disorder 8-03-2023, 18:00

VistaJet and Dr. Barbara Sturm Unveil Exclusive Global Partnership 7-05-2025, 15:00

Fluence Stands by its Work on the Diablo Plant, and Will Vigorously Pursue the Payments it is Owed for its Work and Dispute the Allegations in the Counterclaim Filed by the Operator of the Plant 21-12-2023, 04:25